|Previous Section||Index||Home Page|
Mark Simmonds: To ask the Secretary of State for Health what the cost to the public purse was of (a) legal costs and (b) damages awarded in respect of clinical negligence cases involving the NHS in each of the last three years. 
|Year claim closed||Damages||Defence legal costs||Claimant legal costs|
1. The data only cover claims made against national health service trusts, NHS foundation trusts or primary care trusts.
2. The year represents the year the claim closed, not the year of incident nor the year the claim was made.
|Number of claims won and lost by the NHSLA by year claims were closed|
|Year claim closed||Number of claimsnil damages won||Number of claims with damages lost|
1. The data only cover claims made against national health services trusts, NHS foundation trusts or primary care trusts.
2. Claims won are claims where the NHSLA did not pay damages. Claims lost are claims where the NHSLA paid damages.
3. The numbers represent the number of cases closed per year, not the number of incidents reported per year nor the number of claims made in a year.
Mark Simmonds: To ask the Secretary of State for Health how many cases of clinical negligence litigation involving the NHS there were in each of the last three financial years; and how many of those cases were financed by legal aid. 
Ann Keen: The NHS Litigation Authority (NHSLA) provided the data requested in the following table. The data only cover claims relating to national health service trusts, NHS foundation trusts, and primary care trusts.
|Number of clinical negligence claims received 1 April 2005 to 31 March 2008 and their claimant funding as at 31 March 2008|
|NHSLA notification year||Before the event insurance||Conditional fee arrangement||Legal services commission||Self funded||Not identified||Total|
Claimants are only required to provide details of funding arrangements if a case proceeds to court.
Mrs. May: To ask the Secretary of State for Health pursuant to the Answer of 26 March 2008, Official Report, column 207W, on NHS questionnaires, how many responses were received for each of the four surveys carried out by Ipsos MORI on behalf of his Department in the financial year 2007-08. 
Results for wave 7 (May 2007) based on 75,191 respondents;
Results for wave 8 (July 2007) based on 62,264 respondents;
Results for wave 9 (September 2007) based on 92,545 respondents; and
Results for wave 10 (November 2007) based on 77,804 respondents.
Ann Keen [holding answer 1 May 2008]: Information on the number of qualified nursery nurses in community services employed by each primary care trust in England since 1995 has been placed in the Library.
Mr. Burstow: To ask the Secretary of State for Health what steps are being taken to provide women with accurate information on how to prevent osteoporotic fractures post-menopause; and if he will make a statement. 
Ann Keen: Through the NHS Choices website, we are providing the public with information to help them make informed decisions about their health, lifestyle choices and any treatments that they need. This includes information on lifestyle factors that may prevent osteoporosis, osteoporosis treatments and advice to reduce the risk of falling.
NHS Choices contains evidence-based information drawn from sources such as NHS Direct and the National Electronic Library for Health and ensures that health professionals are able to refer their patients to a comprehensive source of information that is quality assured.
Mr. Burstow: To ask the Secretary of State for Health what estimate he has made of the cost of treating fractures resulting from osteoporosis in London, broken down by primary care trust area in the most recent period for which figures are available; and if he will make a statement. 
Ann Keen: The information requested is not collected centrally. However, information is available on the average cost to national health service providers of providing a range of fracture treatments. This information is collected each year through the NHS reference cost collection exercise. Copies of the national schedule of reference costs for 2006-07, NHS Reference Costs 2006-07, are available in the Library. The information is also available on the Departments website at:
Our White Paper Pharmacy in England, Building on strengths, delivering the future sets out a number of proposals for structural reform including market entry. We are currently holding public events to hear views on these on which there will be full consultation later this summer.
Mr. Stephen O'Brien: To ask the Secretary of State for Health when he expects the Information Centre to publish proposals for the use of practice-level prescribing data, as announced in the Information Centre's presentation to the Inaugural Supplier Forum of 7 November 2007; whether he intends to ask the Information Centre to consult on these proposals; and if he will make a statement. 
Dawn Primarolo: The Information Centre for health and social care agreed to produce a review document seeking to determine whether it will be possible to make practice-level prescribing data more accessible to the private sector with due regard to appropriate legislation, current departmental policy and the professional regulations of those involved in the supply of prescriptions.
Mr. Spellar: To ask the Secretary of State for Health what assessment he has made of the actions of the Human Tissue Authority in the case of Laura Ashworth and Rachel Leake; and if he will make a statement. 
There has been a long established principle that donated organs from deceased donors are matched and allocated to the person on the transplant waiting list who is most in need and who provides the best match.
Mr. Ivan Lewis: Drug-resistant tuberculosis (TB) arises mostly from either poor or incomplete previous treatment of TB. The key to tackling drug resistance is to prevent it developing in the first place, and our strategy is focused on strengthening national health service TB services to improve early case detection and completion of treatment.
The TB Toolkit launched last year provides models of best practice for the national health service to deliver TB services. We have also funded the British Thoracic Society to establish a clinical advisory
network to advise on treatment of drug-resistant cases. We are also funding work to raise awareness of TB among health care professionals and groups at higher risk of TB.
Mr. Mullin: To ask the Secretary of State for Health (1) if he will list each of the consultations undertaken on the provision of stoma and incontinence appliances, giving in each case the dates of commencement and closure; when he expects the process to be complete; how much is has cost; and if he will make a statement; 
Dawn Primarolo: The current review of the arrangements under Part IX of the Drug Tariff for the provision of stoma and incontinence appliancesand related servicesin primary care began in October 2005 and has followed the following timetable:
|Next Section||Index||Home Page|